Tiagabine Hydrochloride
- Product NDC
- 72205-087
- 11-digit product format
- 722050087
- Labeler code
- 72205
- Product ID
- 72205-087_7c034fe0-cdac-49e1-8e39-592846ea3bec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tiagabine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Novadoz Pharmaceuticals LLC
- Application
- ANDA214816
- Marketing category
- ANDA
- Marketing start
- 2021-11-23
- Substance
- TIAGABINE HYDROCHLORIDE
- Active strength
- 16 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tiagabine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIAGABINE HYDROCHLORIDE | 16 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | DQH6T6D8OY |
| Rxcui | 1299903, 1299909, 1299911, 1299917 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72205-087-30 | Tiagabine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72205-087 | TIAGABINE HYDROCHLORIDE TABLET [NOVADOZ PHARMACEUTICALS LLC] | 1 | Current NDC, Legacy NDC, 1 package rows | 20211124_7c034fe0-cdac-49e1-8e39-592846ea3bec.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72205-087-30 | 72205008730 | 30 TABLET in 1 BOTTLE (72205-087-30) | 30 tablet | 2021-11-23 | 0000-00-00 | No | No | Current |